Eutectic-Driven Recrystallization of Coamorphous Bicalutamide + Niclosamide Systems: Contrasting Stability above and below T g
Molecular Pharmaceutics · 06.07.2026 · 23 (7) · 3641-3653
DOI: 10.1021/acs.molpharmaceut.5c01958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 09.06.2026. Verfasst von Paulina Poloczek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physics, University of Silesia in Katowice, 75 Pułku Piechoty 1A, Chorzów 41-500, Poland. Hauptthemen laut MEDLINE: Anilides, Niclosamide, Nitriles, Tosyl Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Uniwersytet Slaski w Katowicach.
Abstract (Originalsprache)
Coamorphization is a promising strategy to enhance the physical stability of poorly water-soluble drugs. However, the relationship between composition, molecular dynamics, and long-term stability remains insufficiently understood. Here, we investigate coamorphous systems composed of bicalutamide (BIC) and niclosamide (NIC), focusing on how the eutectic composition defined in the crystalline state translates into molecular dynamics and long-term physical stability of the corresponding amorphous systems above and below the glass transition temperature (Tg). Thermal analysis revealed a eutectic point in the close vicinity of 25 wt % NIC, enabling safe melt-based amorphization of NIC without thermal degradation. Broadband dielectric spectroscopy showed that the addition of NIC does not significantly affect the molecular mobility of amorphous BIC, as reflected by comparable Tg values oscillating around 328 K, fragility parameters in the range of 85–92, as well as similar α-relaxation dynamics across all compositions. Despite these similarities, the physical stability of the coamorphous systems exhibits a pronounced composition dependence. Under accelerated conditions in the supercooled liquid state (T > Tg), the coamorphous system corresponding to the eutectic concentration displays the highest resistance to recrystallization. In contrast, long-term X-ray diffraction studies performed under glassy-state conditions (T < Tg) reveal a different stability ranking. These findings indicate that the stabilization observed for compositions corresponding to the eutectic point depends on the thermal regime and emphasize the importance of evaluating physical stability under both supercooled liquid and glassy state conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Physics, University of Silesia in Katowice, 75 Pułku Piechoty 1A, Chorzów 41-500, Poland.
- Research Center for Macromolecules and Biomaterials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.
- Graduate School of Science and Technology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
ORCID-Profile: Justyna Knapik-Kowalczuk, Kohsaku Kawakami, Marian Paluch
Förderung
- Narodowe Centrum Nauki
- Uniwersytet Slaski w Katowicach
Zitieren
APA
Poloczek, P., Knapik-Kowalczuk, J., Klimontko, J., Han, X., Kawakami, K., & Paluch, M. (2026). Eutectic-Driven Recrystallization of Coamorphous Bicalutamide + Niclosamide Systems: Contrasting Stability above and below T g. Molecular Pharmaceutics, 23(7), 3641-3653. https://doi.org/10.1021/acs.molpharmaceut.5c01958
Vancouver
Poloczek P, Knapik-Kowalczuk J, Klimontko J, Han X, Kawakami K, Paluch M. Eutectic-Driven Recrystallization of Coamorphous Bicalutamide + Niclosamide Systems: Contrasting Stability above and below T g. Molecular Pharmaceutics. 2026;23(7):3641-3653. doi:10.1021/acs.molpharmaceut.5c01958
BibTeX
@article{Poloczek2026,
author = {Poloczek, Paulina and Knapik-Kowalczuk, Justyna and Klimontko, Joanna and Han, Xue and Kawakami, Kohsaku and Paluch, Marian},
title = {Eutectic-Driven Recrystallization of Coamorphous Bicalutamide + Niclosamide Systems: Contrasting Stability above and below T g},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {7},
pages = {3641--3653},
doi = {10.1021/acs.molpharmaceut.5c01958}
}
EUVIMED